Skip to main content
Premium Trial:

Request an Annual Quote

Steven Riedmuller

Steven Riedmuller is the new CEO for Maxygen, a service provider for clients in synthetic biology, metabolic engineering, gene therapy, immunotherapy, and gene editing. Riedmuller most recently served as senior director for field applications at Synthetic Genomics. Prior to that, he was VP of engineering and business development at Hudson Robotics.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.